brigatinib 30 MG Oral Tablet

RxCUI: 1921222
RxNorm name: brigatinib 30 MG Oral Tablet
Display name: brigatinib 30 MG Oral Tablet
Full name: brigatinib 30 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Alunbrig	BRIGATINIB	Takeda Pharmaceuticals America, Inc.	0fe9ff20-d402-41f3-bc1e-7002ea7007db	2026-01-12	Warnings, Adverse reactions	Exact identifier rxcui: 1921222

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
0fe9ff20-d402-41f3-bc1e-7002ea7007db	brigatinib 30 MG Oral Tablet [PSN] · brigatinib 30 MG Oral Tablet [SCD]	2	17	These highlights do not include all the information needed to use ALUNBRIG safely and effectively. See full prescribing information for ALUNBRIG. ALUNBRIG ® (brigatinib) tablets, for oral use Initial U.S. Approval: 2017	20260112